Hans Kaspersetz

Hans Kaspersetz is a seasoned executive with over 24 years of experience in healthcare marketing and technology, currently serving as the Chief Executive Officer at Oralucent, where focus is on revolutionizing oral care through innovative light therapy technology. In addition to this role, Hans holds positions as Chief Technology Advisor and Chief Technology Officer at Intercept Telehealth and serves as a strategic advisor for Chillshark Inc and ZapCap. As a Venture Partner at New World Angels, involvement includes evaluating investment proposals and conducting due diligence. Prior roles include Founder and Chief Innovation Officer at Relevate Health and Founder and President at Arteric, where significant growth and innovation were achieved. Education was completed at Rutgers University - Newark and St. Peters Prep.